NCT05519098View on ClinicalTrials.gov

COLO-SW-1 Pivotal Clinical Investigation

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

August 23, 2022

Primary Completion Date

October 26, 2022

Study Completion Date

October 26, 2022

Conditions
ColonoscopyAdenoma Colon
Interventions
DEVICE

COLO-SW-1

Patient will undergo a CADe-assisted colonoscopy procedure with use of the COLO-SW-1 software.

Trial Locations (2)

41345

Sahlgrenska University Hospital-Mölndal, Gothenburg

0450

Oslo University Hospital, Oslo

Sponsors

Lead Sponsor

Augere Medical AS
All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

lead

Augere Medical AS

INDUSTRY

NCT05519098 - COLO-SW-1 Pivotal Clinical Investigation | Biotech Hunter | Biotech Hunter